৳ 0.00
Your Complete HealthCare Solution - Right Here
10657
info@shukhee.com
Telecom Bhaban (Level- 12), 53/1 Box Nagar, Zoo Road, Dhaka-1216.
৳ 0.00
10657
info@shukhee.com
Telecom Bhaban (Level- 12), 53/1 Box Nagar, Zoo Road, Dhaka-1216.



Quantity:
Products
Payment
Delivery
Indications
Prophylaxis and treatment of haemorrhagic disease in the newborn.
Haemorrhage or risk of haemorrhage due to severe hypoprothrombinemia (deficiency of clotting factors II, VII, IX, X) from various causes, including:
Overdosage of coumarin-type anticoagulants
Combination with phenylbutazone
Hypovitaminosis K (e.g., obstructive jaundice, liver/intestinal disorders, prolonged use of antibiotics, sulphonamides, salicylates)
Prevention and treatment of bleeding due to vitamin K deficiency.
Pharmacology
Phytomenadione (Vitamin K1) is a procoagulant factor.
It acts as a cofactor in hepatic carboxylase system, enabling post-translational carboxylation of clotting factors II, VII, IX, X and inhibitors protein C & S.
Deficiency leads to haemorrhagic disease, especially in newborns.
Administration restores synthesis of coagulation factors, reversing abnormal coagulation and bleeding.
Ineffective in hereditary hypoprothrombinemia or hypoprothrombinemia due to severe hepatic failure.
Dosage & Administration
Prophylaxis (Neonates):
2 mg orally at birth or just after.
2 mg on 4th–5th day.
2 mg on 28th–30th day.
If oral route unsuitable → 2 mg IM or IV.
Children >1 year: 5–10 mg orally.
Single 1 mg IM if oral doses uncertain (especially breast-fed infants).
Therapy: Initially 1 mg IV, further doses as required based on coagulation status.
Neonates with risk factors (prematurity, birth asphyxia, obstructive jaundice, maternal anticoagulant/antiepileptic use):
1 mg IM/IV at birth if oral route unsuitable.
IM/IV dose should not exceed 0.4 mg/kg in premature infants <2.5 kg.
Further doses based on coagulation status.
Total protection requires 3 prophylactic oral doses as per schedule.
Interactions
Antagonises coumarin-type anticoagulants.
Anticonvulsants may impair Vitamin K1 action.
Contraindications
Hypersensitivity to any constituent.
Side Effects
Rare reports of anaphylactoid reactions, venous irritation, or phlebitis after parenteral use.
Precautions & Warnings
Careful monitoring of coagulation parameters is necessary in patients with severe liver impairment.





KMM Paediatric Oral/IM/IV injection is a medicine used to treat vitamin K deficiency in the body. It helps in improving conditions caused due to low levels of vitamin K in the body. Vitamin K is an important nutrient which is necessary for blood clotting and bone metabolism.\n\nKMM Paediatric Oral/IM/IV injection is given under the supervision of a healthcare professional and should not be self-administered. You should take it regularly to get the most benefit from it. This medicine may be only part of a complete program of treatment that also includes making changes to your diet and taking vitamin supplements.\n\nKMM Paediatric Oral/IM/IV injection is generally safe with little or no side effects. However, it may cause pain, redness or swelling at the site of injection in some people.\n\nBefore taking this medicine, let your doctor know all other medicines you are taking to make sure you are safe. It is important to ask advise of the doctor before taking any other vitamin supplements.
Your doctor or nurse will give you this medicine. Kindly do not self administer.
KMM Paediatric Oral/IM/IV injection is a synthetic form of vitamin K. It restores the activity of vitamin K and speeds up the normal blood clotting process to prevent or treat bleeding caused due to too high dose of warfarin.
